doi: 10.1542/peds.2008-1573.
Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder
- PMID:18676566
- DOI: 10.1542/peds.2008-1573
Item in Clipboard
Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder
James M Perrin et al. Pediatrics.2008 Aug.
Display options
Format
Display options
Format
No abstract available
Similar articles
- Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.Newcorn JH, Donnelly C.Newcorn JH, et al.Mt Sinai J Med. 2009 Apr;76(2):198-203. doi: 10.1002/msj.20096.Mt Sinai J Med. 2009.PMID:19306385No abstract available.
- Stimulants for kids with ADHD--how to proceed safely.Ken Mehta S, Jacobs I.Ken Mehta S, et al.J Fam Pract. 2014 Feb;63(2):E1-5.J Fam Pract. 2014.PMID:24527478
- Stimulants and sudden death: what is a physician to do?Wilens TE, Prince JB, Spencer TJ, Biederman J.Wilens TE, et al.Pediatrics. 2006 Sep;118(3):1215-9. doi: 10.1542/peds.2006-0942.Pediatrics. 2006.PMID:16951018Review.
- [Treatment with central nervous system stimulants. Practical guidelines].Hvolby A, Jørgensen JI.Hvolby A, et al.Ugeskr Laeger. 2004 Jan 12;166(3):144-8.Ugeskr Laeger. 2004.PMID:14870640Danish.No abstract available.
- Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.Merkel RL.Merkel RL.Expert Opin Drug Saf. 2010 Nov;9(6):917-35. doi: 10.1517/14740338.2010.503238.Expert Opin Drug Saf. 2010.PMID:20615078Review.
Cited by
- Screening electrocardiograms in psychiatric research: implications for physicians and healthy volunteers.Pavletic AJ, Pao M, Pine DS, Luckenbaugh DA, Rosing DR.Pavletic AJ, et al.Int J Clin Pract. 2014 Jan;68(1):117-21. doi: 10.1111/ijcp.12218.Int J Clin Pract. 2014.PMID:24341305Free PMC article.
- Adult attention-deficit/hyperactivity disorder treatment and cardiovascular implications.Hammerness PG, Surman CB, Chilton A.Hammerness PG, et al.Curr Psychiatry Rep. 2011 Oct;13(5):357-63. doi: 10.1007/s11920-011-0213-3.Curr Psychiatry Rep. 2011.PMID:21698412Review.
- Promoting productive interactions between parents and physicians in the treatment of children with attention-deficit/hyperactivity disorder.Brinkman WB, Epstein JN.Brinkman WB, et al.Expert Rev Neurother. 2011 Apr;11(4):579-88. doi: 10.1586/ern.10.151.Expert Rev Neurother. 2011.PMID:21469930Free PMC article.Review.
- Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.Olfson M, Huang C, Gerhard T, Winterstein AG, Crystal S, Allison PD, Marcus SC.Olfson M, et al.J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):147-56. doi: 10.1016/j.jaac.2011.11.008. Epub 2011 Dec 20.J Am Acad Child Adolesc Psychiatry. 2012.PMID:22265361Free PMC article.
- Drug therapy of attention deficit hyperactivity disorder: current trends.De Sousa A, Kalra G.De Sousa A, et al.Mens Sana Monogr. 2012 Jan;10(1):45-69. doi: 10.4103/0973-1229.87261.Mens Sana Monogr. 2012.PMID:22654382Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical